Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics.

Abstract

Cardiac glycosides are natural sterols and constitute a group of secondary metabolites isolated from plants and animals. These cardiotonic agents are well recognized and accepted in the treatment of various cardiac diseases as they can increase the rate of cardiac contractions by acting on the cellular sodium potassium ATPase pump. However, a growing number of recent efforts were focused on exploring the antitumor and antiviral potential of these compounds. Several reports suggest their antitumor properties and hence, today cardiac glycosides (CG) represent the most diversified naturally derived compounds strongly recommended for the treatment of various cancers. Mutated or dysregulated transcription factors have also gained prominence as potential therapeutic targets that can be selectively targeted. Thus, we have explored the recent advances in CGs mediated cancer scope and have considered various signaling pathways, molecular aberration, transcription factors (TFs), and oncogenic genes to highlight potential therapeutic targets in cancer management.

• Authors: Ranjith Kumavath, Sayan Paul, Honey Pavithran, Manash K Paul, Preetam Ghosh, Debmalya Barh, Vasco Azevedo
• Journal: Biomolecules (Biomolecules) Vol. 11 Issue 9 (08 25 2021) ISSN: 2218-273X [Electronic] Switzerland
• PMID: 34572488 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review)

Chemical References

• Cardiac Glycosides
• Transcription Factors

Topics

• Animals
• Apoptosis (drug effects)
• Cardiac Glycosides (pharmacology, therapeutic use)
• Clinical Trials as Topic
• Humans
• Molecular Docking Simulation
• Neoplasms (drug therapy, pathology)
• Transcription Factors (metabolism)